Skip to main content
Clinical Trials/NCT01094639
NCT01094639
Completed
Not Applicable

Periodontal Infection and Systemic Inflammation in Renal Patients

UConn Health1 site in 1 country52 target enrollmentAugust 2009

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Periodontitis
Sponsor
UConn Health
Enrollment
52
Locations
1
Primary Endpoint
Serum Interleukin-6 (IL-6) and C-reactive protein (CRP) levels
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The purpose of this study is to examine the role of gum disease in affecting the long term prognosis of renal patients. This disease if untreated causes inflammatory response throughout the body. If the subject has gum disease, he/she will be randomly assigned to one of the two treatment groups. The study investigates what happens to inflammatory markers in blood and saliva after you are treated for gum disease.

Detailed Description

The main goal of this project was to explore the contribution of chronic periodontitis to systemic inflammation in Chronic Kidney Disease (CKD). To achieve this goal, the project had two specific objectives: 1. a) To compare the prevalence of periodontal infection between CKD and non-CKD populations and b) to explore the association between the presence of periodontal infection and the uremic status of CKD patients. 2. a) To assess the levels of systemic inflammatory markers, IL-6 and CRP in the presence or absence of periodontal infection in CKD and b) to compare the serum IL-6 and CRP levels in response to periodontal intervention.

Registry
clinicaltrials.gov
Start Date
August 2009
End Date
August 2015
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
UConn Health
Responsible Party
Principal Investigator
Principal Investigator

Efthimia Ioannidou

Associate Professor

UConn Health

Eligibility Criteria

Inclusion Criteria

  • dental subjects with periodontitis,
  • at least 10 teeth
  • no periodontal (gum) treatment for the last year,
  • no antibiotic for the last 4 months,
  • no vascular access infection.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Serum Interleukin-6 (IL-6) and C-reactive protein (CRP) levels

Time Frame: 2 months

IL-6 and CRP are markers of systemic inflammation and may improve at the end of gum treatment.

Secondary Outcomes

  • Changes in periodontal (gum) clinical presentation and status(2 months)

Study Sites (1)

Loading locations...

Similar Trials